Baijieyi

Interleukin-11 · Angde Biotech Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Baijieyi, covering 2017-02-10 to 2017-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor

See pricing